During this first week, your expectations should be centered around observing your bodys subtle changes
It may also help to boost compliance when injectables are not preferred and could be priced lower to reach a broader swathe of patients, especially outside the United States. Morgan Stanley: A broader and more lasting behavioral shift According to recent research from Morgan Stanley, its biopharma analysts expect the US anti-obesity medication (AOM) patient pool to increase fivefold to 24 million people (7% of the US population) over the next decade
While semaglutide is not known to cause liver issues directly, its important to contact a healthcare provider if this change occurs
3 After roughly 18 months, participants lost about 10 percent of body weight, and average total testosterone increased by 18 percent, suggesting that weight reduction from GLP-1 therapy may help reverse obesity-related low testosterone
Contact your PlexusDx provider before making the change to ensure it aligns with your treatment plan
For most people, these effects were mild to moderate and faded over time, and fewer than 7% stopped taking the medication because of them
